NewsWPLG Local 10 – Main FeedAugust 20, 2026Miami-Dade
World Health Organization allocates 70,000 doses of Ervebo vaccine to Congo for Ebola outbreak
The World Health Organization and partners are sending 70,000 doses of the Ervebo vaccine to Congo to address the current Ebola outbreak. While the vaccine is licensed for a different strain of the virus, it will be used for front-line health workers and a clinical trial to determine its effectiveness against the current Bundibugyo virus strain.
Read the full story at WPLG Local 10 – Main FeedWhy It Matters
This deployment represents a major international effort to contain the fastest-spreading Ebola outbreak in history, which has already resulted in 2,476 deaths.
Key Facts
- 70,000 total doses of Ervebo vaccine are being sent to Congo.
- 20,000 doses are designated for a Phase 3 clinical trial to test efficacy against the Bundibugyo virus.
- 50,000 doses are designated for front-line and health workers.
- The current outbreak has caused 2,476 deaths out of 5,208 confirmed cases.
- The overall case fatality rate is 47.5%, reaching up to 70% in North Kivu province.
- The outbreak is spreading three times faster than the 2014-2016 West Africa outbreak.
- The Ervebo vaccine is not currently licensed for the specific Bundibugyo virus strain causing this outbreak.
- The outbreak was officially declared on May 15, though experts believe it began as early as February.
- The virus is currently spreading in six provinces in eastern Congo.
Who's Mentioned
personTedros Adhanom Ghebreyesus“WHO Director-General.”locationMongbwalu“Mining town where the virus is believed to have originated.”organizationWorld Health Organization“Lead agency coordinating the vaccine distribution.”locationNorth Kivu“Province with a 70% fatality rate.”locationCongo“The country currently experiencing the Ebola outbreak.”